Stoke Therapeutics, Inc.
STOK
$33.61
$0.631.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 138.47% | 150.68% | 146.32% | 15.01% | -1.99% |
| Total Depreciation and Amortization | -16.88% | -16.15% | -14.13% | -11.83% | -7.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.55% | 10.53% | 8.83% | 3.31% | 3.35% |
| Change in Net Operating Assets | -135.38% | -285.56% | -144.34% | -366.67% | -2.02% |
| Cash from Operations | 162.68% | 177.04% | 182.52% | -7.13% | -1.83% |
| Capital Expenditure | -23.08% | 32.69% | 76.56% | 87.44% | 78.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.63% | -239.15% | -260.92% | -199.73% | -180.66% |
| Cash from Investing | -33.58% | -235.43% | -265.21% | -201.44% | -182.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.93% | -91.82% | 1,252.13% | 147.31% | 201.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.93% | -91.82% | 1,252.13% | 147.31% | 201.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.34% | -6,581.50% | 920.39% | -181.19% | -152.18% |